Novo Nordisk A/S Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (44)

Latest Posts

About This Stock More About This Stock
Novo Nordisk (NVO) Beats On Q2 Earnings, Revenues Miss
Article By: Zacks Investment Research
Friday, August 11, 2017 3:00 PM EDT
Novo Nordisk A/S NVO reported second-quarter 2017 earnings of 59 cents per American Depositary Receipt (ADR) beating the Zacks Consensus Estimate of 56 cents by 5.4%. In fact, the reported earnings were in line with the year ago figure.
In this article: NVO Also: ENZ, SNY, ADRO
Read
E Alternative Investments
Article By: Vivian Lewis
Wednesday, August 2, 2017 8:30 AM EDT
In Q2 despite the official level of Wall Street having risen across the board, the Swiss managed to lose money because they bought the market rather than trying to buy winners, like the US tech stocks.
In this article: MFD, AZSEY, FCGYF, PONDX, GLD, AAIGF, TTM, IIF, NVO, RHHBY, RNSHF
Read
E Bull In A China Bourse
Article By: Vivian Lewis
Saturday, June 24, 2017 2:16 PM EDT
It has become standard here in Britain to favor the FTSE 100 over broader UK indexes, because of its multinational company focus. Broader UK indexes depend on consumer spending which is down sharply.
In this article: AGU, ALV, BCS, CAE, CPA, CX, GSK, MXE, NOK, NVO, POT, SLB, SAN, DGRLY, DNACF, MXCHF, NPSNY, NTDOY, OROCF, RHHBY, SLFPY, TCTZF, INFY, SHPG, TEVA, RBGLY, FBASF, VRGDF
Read
Biotechs Are Looking Interesting Here…
Article By: Michael Lamothe
Monday, June 5, 2017 9:47 AM EDT
Growth stock scans on ChartYourTrade MRI.
In this article: NVO, OSUR, SUPN
Read
Premarket Biotech Digest – BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1
Article By: KKD Healthcare Analytics
Monday, April 24, 2017 10:03 AM EDT
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
In this article: BCR, JNJ, MRK, NVO, VNLPF, XOMA, EYEG, ARGNF, BDX
Read

PARTNER HEADLINES

Latest Tweets for $NVO

No tweets yet!